Global Inhaled Nitric Oxide Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Gas and Delivery Systems.

By Application;

Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn118604074 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Inhaled Nitric Oxide Market (USD Million), 2021 - 2031

In the year 2024, the Global Inhaled Nitric Oxide Market was valued at USD 922.96 million. The size of this market is expected to increase to USD 1,561.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.8%.

The global market for inhaled nitric oxide (iNO) plays a pivotal role in respiratory care, offering a crucial therapeutic intervention for patients grappling with various pulmonary conditions. iNO, a colorless and odorless gas, acts as a potent vasodilator by selectively dilating the pulmonary vasculature, thereby enhancing oxygenation in the lungs. This therapeutic attribute renders iNO indispensable in treating conditions such as hypoxic respiratory failure, pulmonary hypertension, and persistent pulmonary hypertension of the newborn (PPHN), where impaired gas exchange and pulmonary vascular constriction significantly impact patient health.

Major stakeholders in the global inhaled nitric oxide market continually innovate delivery systems and formulations to ensure the safe and efficacious administration of iNO therapy. These systems encompass specialized gas cylinders, delivery devices, and monitoring equipment designed to regulate iNO dosage and monitor patient response accurately. With advancements in technology and the advent of portable and user-friendly devices, healthcare providers can optimize iNO therapy delivery across various clinical settings, including intensive care units, neonatal intensive care units, and cardiac catheterization laboratories.

Given the ongoing challenges posed by respiratory diseases worldwide, the demand for inhaled nitric oxide therapy is poised for steady growth. Factors such as the escalating prevalence of respiratory conditions, advancements in medical technology, and increased awareness regarding the therapeutic benefits of iNO contribute to market expansion. Moreover, ongoing research and clinical trials exploring iNO therapy's efficacy in novel indications underscore its potential to address unmet medical needs and enhance patient outcomes in respiratory care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Global Inhaled Nitric Oxide Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers:
        1. Growing Incidence of Respiratory Disorders
        2. Advancements in Healthcare Technology
        3. Expanded Applications in Neonatal Care
      2. Restraints:
        1. High Cost of Treatment
        2. Limited Awareness and Access
        3. Potential Side Effects and Safety Concerns
      3. Opportunities:
        1. Emerging Applications in Adult Respiratory Care
        2. Expansion in Developing Healthcare Markets
        3. Technological Innovations and Product Development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Inhaled Nitric Oxide Market, By Product, 2021 - 2031 (USD Million)
      1. Gas
      2. Delivery Systems
    2. Global Inhaled Nitric Oxide Market, By Application, 2021 - 2031 (USD Million)
      1. Neonatal Respiratory Treatment
      2. Asthma and COPD
      3. Acute Respiratory Distress Syndrome
      4. Malaria Treatment
      5. Tuberculosis Treatment
      6. Others
    3. Global Inhaled Nitric Oxide Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Nu-Med Plus
      2. Praxair Technology, Inc.
      3. Air Liquide Healthcare
      4. Mallinckrodt
      5. Merck KGaA
  7. Analyst Views
  8. Future Outlook of the Market